How to Improve your Grant Proposal Assessment, revisions, etc. Thomas S. Buchanan.

Slides:



Advertisements
Similar presentations
ing%20for%20Success.pdf Information from NIH: Louis V. De Paolo NICHD Roger G. Sorensen.
Advertisements

Yiu-fai Cheung, MD Department of Paediatrics and Adolescent Medicine LKS Faculty of Medicine The University of Hong Kong Hong Kong, China Sharing in GRF.
How your NIH grant application is evaluated and scored Larry Gerace, Ph.D. June 1, 2011.
How Your Application Is Reviewed Robert Elliott, Ph.D. Scientific Review Officer (SRO)
Session 5 Intellectual Merit and Broader Significance FISH 521.
B IOMEDICAL E NGINEERING Significance & Innovation Dawn M Elliott, PhD.
Grant Writing: Specific Aims and Study Design Zuo-Feng Zhang, MD, PhD EPIDEMIOLOGY
Website: where you can find all necessary forms! NIH Grant Writing 101 ASCEND March 2015.
Environment - Facilities/Equipment Randall Duncan Biological Sciences COBRE Grant Writing Workshop January 21, 2015.
Significance and Innovation Significance- The positive effect something is likely to have on other things Innovation- A new and substantially different.
Grant Writing Thomas S. Buchanan NIH Review Process Study Sections Review Criteria Summary Statement Responding to a Review.
How Your Application Is Reviewed Vonda Smith, Ph.D. Scientific Review Officer (SRO)
PRESENTER: DR. ROBERT KLESGES PROFESSOR OF PREVENTIVE MEDICINE UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER AND MEMBER, DEPARTMENT OF EPIDEMIOLOGY AND.
NIH Mentored Career Development Awards (K Series) Part 4
Creating a Research Plan for a Career Development Award Jill Harkavy-Friedman, Ph.D.
Formulating an important research question Susan Furth, MD, PhD Welch Center for Prevention, Epidemiology and Clinical Research
THE NIH REVIEW PROCESS David Armstrong, Ph.D.
UAMS Department of Biochemistry and Molecular Biology
Policy WG NIH policy proposal. Goal: Incorporating global access licensing as one of the additional review criteria Question 1: Should we propose this.
Writing Successful Research Grant Proposals
Navigating the Changes to the NIH Application Instructions Navigating the Changes to the NIH Application Instructions EFFECTIVE JANUARY 25, 2010.
A Review of Recent Changes to NIH Forms & Instructions Jane Tolbert ORPA December 15, 2009.
Michael A. Sesma, Ph.D.; NIMH What Is A Strong Grant Application? What Is A Strong Grant Application? Simple steps to a successful grant application Michael.
Avrom Caplan, PhD Associate University Dean for Research
1 Introduction to Grant Writing Beth Virnig, PhD Haitao Chu, MD, PhD University of Minnesota, School of Public Health December 11, 2013.
Randolph Hall Vice President for Research University of Southern California Funding Strategy Workshop.
COMPONENTS OF A GOOD GRANT PROPOSAL Philip T. LoVerde.
Research Project Grant (RPG) Retreat K-Series March 2012 Bioengineering Classroom.
R01 NIH Grants John E. Lochman, PhD, ABPP Center for Prevention of Youth Behavior Problems Department of Psychology Psychosocial Development, Risk and.
NIH Challenge Grants in Health and Science Research RFA OD
The NIH Grant Review Process Hiram Gilbert, Ph.D. Dept. of Biochemistry, Baylor College of Medicine Xander Wehrens, M.D. Ph.D. Dept. of Molecular Physiology.
Presubmission Proposal Reviews at the College of Nursing (CON) Nancy T. Artinian, PhD, RN, FAAN Associate Dean for Research and Professor.
NATIONAL INSTITUTES OF HEALTH CHALLENGE GRANT APPLICATIONS Dan Hoyt Survey, Statistics, and Psychometrics(SSP) Core Facility March 11, 2009.
1 Preparing an NIH Institutional Training Grant Application Rod Ulane, Ph.D. NIH Research Training Officer Office of Extramural Research, NIH.
Grant writing 101 The Art of Flawless Packaging Scott K. Powers Department of Applied Physiology and Kinesiology Scott K. Powers Department of Applied.
G RANTSMANSHIP $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $
Randolph Hall Vice President for Research University of Southern California Funding Strategy Workshop.
Career Development Awards (K series) and Research Project Grants (R series) Thomas Mitchell, MPH Department of Epidemiology & Biostatistics University.
Ronald Margolis, Ph.D. National Institute of Diabetes, Digestive and Kidney Diseases Amanda Boyce, Ph.D. National Institute of Arthritis and Musculoskeletal.
How is a grant reviewed? Prepared by Professor Bob Bortolussi, Dalhousie University
Restructured NIH Applications One Year Later:
OCTOBER 18, 2011 SESSION 9 OF AAPLS – SELECTED SUPPORTING COMPONENTS OF SF424 (R&R) APPLICATION APPLICANTS & ADMINISTRATORS PREAWARD LUNCHEON SERIES Module.
ENHANCING PEER REVIEW: GUIDE FOR REVIEW OF RESTRUCTURED GRANT APPLICATIONS.
Pilot Grant Program EGAD Study OCCUPATIONAL & ENVIRONMENTAL HEALTH.
Randolph Hall Vice President for Research University of Southern California Funding Strategy Workshop.
Funding Opportunities for Investigator-initiated Grants with Foreign Components at the NIH Somdat Mahabir, PhD, MPH Program Director Epidemiology and Genetics.
Short and Sweet: Selling Your Science in 12 Pages ASBMR Grant Writing Workshop Friday, 15 October 2010 Toronto, ON Jane E. Aubin, Ph.D. Dept of Molecular.
R01? R03? R21? How to choose the right funding mechanism Thomas Mitchell, MPH Department of Epidemiology & Biostatistics University of California San Francisco.
Critiquing Quantitative Research.  A critical appraisal is careful evaluation of all aspects of a research study in order to assess the merits, limitations,
Research Strategy: Approach Frank Sellke, MD Division of Cardiothoracic Surgery Brown Medical School Providence RI AATS Grant Course 2011.
University of Virginia Innovation – How to Make Your Grant New and Unique Grant Writing Workshop American Association for Thoracic Surgery David R. Jones.
NIH R03 Program Review Ning Jackie Zhang, MD, PhD, MPH College of Health and Public Affairs 04/17/2013.
Reviewers Expectations Peter Donkor. Outline Definitions The review process Common mistakes to avoid Conclusion.
What is a Grant? A description of a research project you want to do? A thoughtful explication of a great new research idea? An intellectual magnum opus.
Identifying Strengths and Weaknesses in Your Proposal
Thomas Mitchell, MA, MPH Department of Epidemiology & Biostatistics
Research and Grant Writing
Grant Writing Information Session
Grant Title PI Name Intended Institute List of Proposed Key Personnel
Research Project Grant (RPG) Retreat R-series
Writing that First Research Grant
Information Session January 18, :00-1:45 pm
Preparing Research Proposals for NSF and NIH April 20, 2018
Dr. Lani (Chi Chi) Zimmerman, UNMC Dr. Bill Mahoney, IS&T
Approach Section: The “Meat” of the Proposal
BU Career Development Grant Writing Course- Session 3, Approach
How to Succeed with NIH: September 28, 2018
UAMS Department of Biochemistry and Molecular Biology
Thomas Mitchell, MA, MPH Department of Epidemiology & Biostatistics
Opportunity fund grants at COM
Presentation transcript:

How to Improve your Grant Proposal Assessment, revisions, etc. Thomas S. Buchanan

Afterwards: the Summary Statement Study section, roster Score, percentile Budget recommendations Summary of the discussion Reviewers ’ critiques

The Critique For R and P grants (e.g., R03, P01), the five scored criteria for research grant applications are Significance, Investigator(s), Innovation, Approach, and Environment. Other grant types have different scored criteria (e.g., K, F, T and S awards) The final score for any grant is based on overall impact.

Overall Impact (R & P awards) “Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following five core review criteria, and additional review criteria (as applicable for the project proposed)”

1. Significance “Does the project address an important problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?”

1. Significance “Does the project address an important problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?”

2. Investigators(s) “Are the PD/PIs, collaborators, and other researchers well suited to the project? If Early Stage Investigators or New Investigators, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?”

3. Innovation “Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?”

3. Innovation “Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?”

4. Approach (1 of 2) “Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed?”

4. Approach (1 of 2) “Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed?”

4. Approach (2 of 2) “If the project involves clinical research, are the plans for 1) protection of human subjects from research risks, and 2) inclusion of minorities and members of both sexes/genders, as well as the inclusion of children, justified in terms of the scientific goals and research strategy proposed?”

5. Enviornment “Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?”

5. Enviornment “Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?”

Additional Review Criteria These additional criteria can influence reviewers’ enthusiasm: Protection of Human Subjects Inclusion of Women, Minorities & Children Vertebrate Animals Biohazards Budget Resource Sharing Plan (Data Sharing Plan, Sharing Model Organisms, & Genome Wide Associate Studies) Probably won’t need this

Afterwards: the Revision Carefully analyze the critiques what was uniformly disliked what should be changed vs. re-explained what additional data could be provided Are there words of encouragement embedded in the criticisms? Are significant strengths mentioned? “... above average enthusiasm… ”

Afterwards: the Revision If the chances for successfully addressing the criticisms seem good, revise Begin with “ Introduction ” addressing reviewers ’ criticisms be gracious, respond positively you may or may not get the same reviewers, but your attitude and effort to respond will be appreciated

Afterwards: the Revision You used to get only 1 chance to revise; after that you had to submit a “ different ” proposal Under current rules, you may revise and resubmit as many times as you please if you were close to the funding cutoff, this may increase your odds of success of course, reviewers may get annoyed

Summary: the “ do ’ s ” Good idea, science, and application Mechanistic, testable hypotheses Convincing, appropriate preliminary data Detailed research plan, based on statistical planning Write clearly, state your case as rationally and convincingly as possible Revise repeatedly before submission

Summary: the “don’ts” Not too simple, not too ambitious the problem must be significant 10 hypotheses is probably too many! Avoid sloppy writing use spell checker, check your grammar Don’t make unsupported statements Don’t wait until the last minute; it shows!

Sample Summary Statements Courtesy of Hank Donahue Go hereGo here!

NIH Peer Review Revealed